Rusmaully, Jennifer
Tvardik, Nastassia
Martin, Diane
Billmann, Régine
Cénée, Sylvie
Antoine, Martine
Blons, Hélène
Laurent-Puig, Pierre
Trédaniel, Jean
Wislez, Marie
Stücker, Isabelle
Guénel, Pascal http://orcid.org/0000-0002-8359-518X
Radoï, Loredana
Funding for this research was provided by:
Institut National du Cancer
Fondation de France
Ligue Contre le Cancer
Article History
Received: 25 December 2020
Accepted: 3 June 2021
First Online: 16 June 2021
Declarations
:
: The WELCA study was approved by the Institutional Review Board of the French National Institute of Health and Medical Research and by the French data Protection Authority (IRB-Inserm, no. 3888 and CNIL no. C13–52). Each study participant gave written informed consent.
: Not applicable.
: Dr. Wislez reports personal fees and non-financial support from Roche, non-financial support from Pfizer, personal fees and non-financial support from Astra Zeneca, personal fees and non-financial support from MSD, grants, personal fees and non-financial support from BMS, personal fees and non-financial support from Boehringer Ingelheim, outside the submitted work.The other authors declare no conflict of interest.